Lumefantrine

CHEMBL38827 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
528.9 g/mol
LogP
8.7
Phase
4

This antimalarial drug is used exclusively in combination with artemether to treat uncomplicated malaria caused by Plasmodium falciparum, including strains resistant to older drugs like chloroquine. It works by accumulating in infected red blood cells and interfering with the parasite's ability to detoxify heme, a byproduct of its digestion of hemoglobin.

Moleküler Ağırlık

528,9000 g/mol

LogP

8,70

TPSA

23,50 Ų

Lipinski RO5

Başarısız

Terapötik Alanlar

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCCCN(CCCC)CC(O)c1cc(Cl)cc2c1-c1ccc(Cl)cc1/C2=C/c1ccc(Cl)cc1

InChI

InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-

Molecular Formula

C30H32Cl3NO

HBD / HBA

1 / 2

Döndürülebilir Bağlar

10

Ağır Atomlar

35

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This antimalarial drug is used exclusively in combination with artemether to treat uncomplicated malaria caused by Plasmodium falciparum, including strains resistant to older drugs like chloroquine. It works by accumulating in infected red blood cells and interfering with the parasite's ability to detoxify heme, a byproduct of its digestion of hemoglobin.

Yes, Lumefantrine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL38827. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6437380. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.